MedPath

Independent and Combined Effects of Aerobic and Resistance Training on Blood Pressure

Not Applicable
Completed
Conditions
Cardiovascular Risk Factor
Registration Number
NCT03734146
Lead Sponsor
Iowa State University
Brief Summary

We compared the effects of 8 weeks of aerobic exercise only, resistance exercise only, or a combination of both on blood pressure in overweight or obese middle-aged adults with elevated blood pressure. Participants engaged in supervised exercise sessions 3 times per week for 60 minutes each session. Outcomes were assessed at baseline and after the 8-week intervention. Extra-intervention physical activity and diet were also assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria
  • Systolic/diastolic blood pressure of 120-159/80-99 mm Hg
  • Non-smoking
  • Overweight or obese, with a body mass index of 25-40 kg/m2
  • Inactive--not meeting the aerobic or resistance physical activity guidelines, which means engaging in less than 150 minutes/wk of moderate intensity aerobic exercise and less than 2 days per week of resistance training over the past 3 months.
Exclusion Criteria
  • Unstable coronary heart disease or decompensated heart failure
  • Severe pulmonary hypertension or aortic stenosis
  • Acute myocarditis, endocarditis, pericarditis, or aortic dissection
  • Other medical condition that is life-threatening or that can interfere or be aggravated by the exercise training such as cancer, uncontrolled diabetes, severe pain or mobility limitations.
  • Premenopausal women or postmenopausal women taking hormonal replacement therapy
  • Pregnant women or anticipated pregnancy via IVF or other medical procedures during the course of the intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in resting blood pressureImmediately before and after the 8 week intervention

resting systolic and diastolic blood pressure

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.